Y Intercept Hong Kong Ltd Purchases New Shares in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Key Points

• Y Intercept Hong Kong Ltd has acquired 49,710 shares of Sabra Healthcare REIT, valued at approximately $868,000, during the first quarter of the year.
• Sabra Healthcare REIT's recent earnings report showed $0.37 EPS for the quarter, surpassing expectations and marking a 10.1% revenue increase compared to the previous year.
• The firm declared a quarterly dividend of $0.30 per share, yielding about 6.59%, while the dividend payout ratio stands at 203.39%.

Y Intercept Hong Kong Ltd purchased a new stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 49,710 shares of the real estate investment trust's stock, valued at approximately $868,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its position in Sabra Healthcare REIT by 379.6% during the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock valued at $36,000 after buying an additional 1,621 shares during the period. Fifth Third Bancorp grew its position in Sabra Healthcare REIT by 110.3% during the first quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock valued at $67,000 after buying an additional 2,011 shares during the period. GF Fund Management CO. LTD. acquired a new stake in Sabra Healthcare REIT during the fourth quarter valued at $74,000. Harbor Capital Advisors Inc. grew its position in Sabra Healthcare REIT by 17.2% during the first quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock valued at $76,000 after buying an additional 642 shares during the period. Finally, IFP Advisors Inc grew its position in Sabra Healthcare REIT by 16.2% during the first quarter. IFP Advisors Inc now owns 5,060 shares of the real estate investment trust's stock valued at $88,000 after buying an additional 706 shares during the period. Institutional investors and hedge funds own 99.40% of the company's stock.

Sabra Healthcare REIT Stock Down 0.8%

Shares of NASDAQ SBRA opened at $18.22 on Friday. The company's 50-day simple moving average is $18.10 and its 200-day simple moving average is $17.46. Sabra Healthcare REIT, Inc. has a 52-week low of $15.60 and a 52-week high of $20.03. The firm has a market cap of $4.34 billion, a price-to-earnings ratio of 30.88, a price-to-earnings-growth ratio of 1.52 and a beta of 0.85. The company has a quick ratio of 4.22, a current ratio of 4.22 and a debt-to-equity ratio of 0.89.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.01. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The business had revenue of $183.54 million for the quarter, compared to analyst estimates of $180.23 million. During the same quarter last year, the business earned $0.35 earnings per share. The company's revenue for the quarter was up 10.1% compared to the same quarter last year. Equities analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, May 30th. Stockholders of record on Friday, May 16th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.59%. The ex-dividend date was Friday, May 16th. Sabra Healthcare REIT's dividend payout ratio is currently 203.39%.

Analyst Ratings Changes

Separately, Scotiabank raised their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $19.67.

Insider Buying and Selling at Sabra Healthcare REIT

In other news, Director Michael J. Foster sold 11,000 shares of the firm's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the transaction, the director directly owned 64,725 shares of the company's stock, valued at approximately $1,179,289.50. This trade represents a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 1.20% of the company's stock.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.